With cutting-edge automation, the facility can produce mRNA material for up to 100,000 doses of a COVID-19 vaccine daily, ...

Shares of Moderna, Inc. ($MRNA), among the frontrunners in mRNA vaccine technology, fell on Tuesday, bucking the broader market strength. The weakness came after Bloomberg reported, citing a person ...

As a key player in protein synthesis, mRNA technology is transforming therapeutics, offering solutions for cancer, genetic disorders, and regenerative medicine.

Singapore has launched Asia's first automated mRNA manufacturing facility, which will speed up vaccine production in the ...

Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine ...

Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...

They each had received an mRNA vaccine for Covid-19 within six weeks of their presentation – 17 after their second dose of ...

Each child had received an mRNA vaccine for Covid-19 within six weeks of their presentation – 17 after their second dose, and ...

Although the world has moved on after the Covid-19 pandemic, there is always a worry if there is global readiness for another ...

How durable are the mRNA Covid vaccines? Does the protection last as long as other vaccines? Experts the vaccines are performing as expected.